Publications by authors named "Runzhe Chen"

33Publications

The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders.

Drug Discov Today 2020 Sep 16. Epub 2020 Sep 16.

College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China; Institute of Cancer and Basic Medicine, Chinese Academy of Sciences; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou 310022, China. Electronic address:

View Article and Find Full Text PDF
September 2020

Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.

J Cancer 2020 9;11(18):5289-5292. Epub 2020 Jul 9.

Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Jiangsu Province, P.R. China.

View Article and Find Full Text PDF
July 2020

COVID-19 Transmission Within a Family Cluster in Yancheng, China.

Front Med (Lausanne) 2020 3;7:387. Epub 2020 Jul 3.

Department of Hematology and Oncology, Medical School, Zhongda Hospital, Southeast University, Nanjing, China.

View Article and Find Full Text PDF
July 2020

Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer.

Front Oncol 2019 24;9:538. Epub 2019 Jul 24.

Department of Respiratory Medicine, The Affiliated Yancheng Hospital, Medical School, Southeast University, Yancheng, China.

View Article and Find Full Text PDF
July 2019

Treatment and prognostic factors for survival in newly diagnosed multiple myeloma patients with bortezomib and dexamethasone regimen: a single Chinese center retrospective study.

Cancer Manag Res 2017 24;9:373-380. Epub 2017 Aug 24.

Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, People's Republic of China.

View Article and Find Full Text PDF
August 2017

Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.

J Cancer 2017 1;8(10):1801-1808. Epub 2017 Jul 1.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, P.R. China.

View Article and Find Full Text PDF
July 2017

Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma.

J Cancer 2017 7;8(5):839-851. Epub 2017 Mar 7.

Department of Hematology and Oncology (Key Discipline of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing 210009, Jiangsu Province, P.R. China.

View Article and Find Full Text PDF
March 2017

Efficacy of carfilzomib in the treatment of relapsed and (or) refractory multiple myeloma: a meta-analysis of data from clinical trials.

Discov Med 2016 10;22(121):189-199

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu 210009, China.

View Article and Find Full Text PDF
October 2016

Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo.

Onco Targets Ther 2016 11;9:4215-24. Epub 2016 Jul 11.

Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province.

View Article and Find Full Text PDF
July 2016

Hepatocellular carcinoma presenting as thoracic spinal canal metastasis with no clinical primary foci: A report of a rare case and review of the literature.

Oncol Lett 2015 Oct 4;10(4):2333-2336. Epub 2015 Aug 4.

Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu 210009, P.R. China.

View Article and Find Full Text PDF
October 2015

CD19 chimeric antigen receptor T cell therapy for the treatment of B cell lineage acute lymphoblastic leukemia.

Discov Med 2015 Oct;20(110):185-90

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Southeast University Medical School, Nanjing, Jiangsu, China.

View Article and Find Full Text PDF
October 2015

Siltuximab (CNTO 328): a promising option for human malignancies.

Drug Des Devel Ther 2015 2;9:3455-8. Epub 2015 Jul 2.

Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
April 2016

Umbilical cord blood transplantation supplemented with the infusion of mesenchymal stem cell for an adolescent patient with severe aplastic anemia: a case report and review of literature.

Patient Prefer Adherence 2015 11;9:759-65. Epub 2015 Jun 11.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
June 2015

Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia.

Onco Targets Ther 2015 24;8:955-7. Epub 2015 Apr 24.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
May 2015

Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies.

Drug Des Devel Ther 2015 21;9:2277-83. Epub 2015 Apr 21.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
February 2016

Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma.

Drug Des Devel Ther 2015 23;9:1729-33. Epub 2015 Mar 23.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
May 2016

Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Onco Targets Ther 2015 10;8:405-12. Epub 2015 Feb 10.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, People's Republic of China.

View Article and Find Full Text PDF
February 2015

The role of dasatinib in the management of chronic myeloid leukemia.

Drug Des Devel Ther 2015 9;9:773-9. Epub 2015 Feb 9.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
May 2016

Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature.

Onco Targets Ther 2015 29;8:265-8. Epub 2015 Jan 29.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
February 2015

Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD.

Patient Prefer Adherence 2015 17;9:105-11. Epub 2015 Jan 17.

Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

View Article and Find Full Text PDF
February 2015